Home > Healthcare > Medical Devices > Therapeutic Devices > Bone Graft Substitutes Market

Bone Graft Substitutes Market Size

  • Report ID: GMI7993
  • Published Date: Jan 2024
  • Report Format: PDF

Bone graft substitutes market Size

Bone Graft Substitutes Market size was valued at around USD 3 billion in 2023 and is estimated to expand at 6.6% CAGR from 2024 to 2032. This robust market growth can be attributed to various factors, including ongoing advancements in technology, increased awareness among patients and healthcare professionals, growing number of surgical procedures, and rising prevalence of orthopedic disorders, among other contributing factors.

 

Moreover, an overall increase in the incidences of orthopedic diseases, such as fractures, joint degeneration, and spinal issues, demands surgical procedures such as bone graft substitutes. The need for bone replacement and grafts increases as more orthopedic procedures are being performed, thus fostering the market growth. For instance, according to the American Academy of Physical Medicine and Rehabilitation, degenerative joint disease affects around 50% of adult individuals over 65 in the U.S. The disorder is associated with pain, loss of function, and decreased stamina, which can lead to weight gain and other impacts.

 

In addition, according to the statistics by World Health Organization (WHO), around 73% of patients with osteoarthritis are above the age of 55, with 60% of them are female. Additionally, continuous advancements in medical technology, such as development of synthetic bone graft materials, spine biologics, and tissue engineering, further enhance the efficacy and safety of bone transplant treatments.

 

Bone graft substitutes refer to medical materials used in orthopedic and dental procedures to facilitate bone healing, regeneration, or fusion. These materials are employed when there is a need to replace or augment bone tissue, such as in cases of fractures, spinal fusion surgeries, joint reconstruction, or dental procedures.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Bone graft substitutes industry reached USD 3 billion in revenue in 2023 and is set to expand at 6.6% CAGR between 2024 and 2032 driven by the ongoing technological advancements and the growing number of surgical procedures.

The allograft type segment recorded USD 2 billion in revenue in 2023 and is estimated to record considerable growth through 2032 owing to their versatility for numerous medical conditions.

North America bone graft substitutes market size was USD 1.3 billion in 2023 and is estimated to grow at a robust growth rate from 2024 to 2032 attributed to the presence of aging population coupled with the growing number of orthopedic diseases in the region.

Some of the prominent bone graft substitute companies are AlloSource, Baxter International Inc., DePuy Synthes (Johnson & Johnson Inc.), Geistlich Pharma AG, Medtronic plc, NuVasive, Inc., Orthofix US LLC., OST Laboratories, Smith + Nephew, Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Bone Graft Substitutes Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 331
  • Countries covered: 22
  • Pages: 160
 Download Free Sample